Human

Intravacc and DZNE awarded EU funding to develop vaccine against genetic ALS variant

Retrieved on: 
Wednesday, July 6, 2022 - 7:00am

The project aims to develop the vaccine candidate identified at DZNE to the point where it can be clinically tested in humans.

Key Points: 
  • The project aims to develop the vaccine candidate identified at DZNE to the point where it can be clinically tested in humans.
  • About 5-10% of all ALS cases are caused by a mutation in the C9orf72 gene, making it the most common genetic ALS variant.
  • DZNE developed an experimental vaccine that instructs the immune system to produce antibodies against these harmful poly-GA molecules.
  • Clinical trials for C9orf72 ALS, which is the most common genetic variant of ALS, are expected to commence in 2025.

Intravacc and DZNE awarded EU funding to develop vaccine against genetic ALS variant

Retrieved on: 
Wednesday, July 6, 2022 - 7:00am

The project aims to develop the vaccine candidate identified at DZNE to the point where it can be clinically tested in humans.

Key Points: 
  • The project aims to develop the vaccine candidate identified at DZNE to the point where it can be clinically tested in humans.
  • About 5-10% of all ALS cases are caused by a mutation in the C9orf72 gene, making it the most common genetic ALS variant.
  • DZNE developed an experimental vaccine that instructs the immune system to produce antibodies against these harmful poly-GA molecules.
  • Clinical trials for C9orf72 ALS, which is the most common genetic variant of ALS, are expected to commence in 2025.

DGAP-News: African Energy Week: Afreximbank President Benedict Oramah will Receive African Energy Person of the Year Award

Retrieved on: 
Wednesday, July 6, 2022 - 7:04am

JOHANNESBURG, South Africa, July 5, 2022/APO Group/ -African Export-Import Bank (Afreximbank) President Benedict Okey Oramah will receive the African Energy Chambers inaugural African Energy Person of the Year during African Energy Week ( www.AECWeek.com ) 2022 in Cape Town in October.

Key Points: 
  • JOHANNESBURG, South Africa, July 5, 2022/APO Group/ -African Export-Import Bank (Afreximbank) President Benedict Okey Oramah will receive the African Energy Chambers inaugural African Energy Person of the Year during African Energy Week ( www.AECWeek.com ) 2022 in Cape Town in October.
  • Dr Oramah, an outstanding advocate for the continent and for a just African energy transition, is a natural choice for this award.
  • Oramah, who holds a doctorate degree in agricultural economics, has been president and chairman of the board of directors of Afreximbank since 2015.
  • The African Energy Chamber is proud to recognize Dr. Oramah, a champion for Africa and a role model for Africans.

Human Horizons Reveals More of Ultra-futuristic Digital GT HiPhi Z

Retrieved on: 
Wednesday, July 6, 2022 - 6:55am

SHANGHAI, July 6, 2022 /PRNewswire/ -- Industry-leading new mobility and intelligent driving technology company, Human Horizons, has recently unveiled more details on the ultra-futuristic digital GT HiPhi Z. Redefining the traditional GT model, the HiPhi Z comes equipped with cutting edge technologies to create an unparalleled next-level driving experience.

Key Points: 
  • SHANGHAI, July 6, 2022 /PRNewswire/ -- Industry-leading new mobility and intelligent driving technology company, Human Horizons, has recently unveiled more details on the ultra-futuristic digital GT HiPhi Z. Redefining the traditional GT model, the HiPhi Z comes equipped with cutting edge technologies to create an unparalleled next-level driving experience.
  • "Designed and manufactured exclusively by Human Horizons, the HiPhi Z is a testament to the company's dedication to technological advancement, sparing no expense in testing the boundaries of creation.
  • Through rigorous testing and development, the HiPhi Z has retained more than 95% of its production intents revealed previously," said Ding Lei, founder, CEO, and chairman of HiPhi.
  • Furthermore, Human Horizons builds smart transportation technologies and contributes to the development of smart cities, which will redefine human mobility.

Human Horizons Reveals More of Ultra-futuristic Digital GT HiPhi Z

Retrieved on: 
Wednesday, July 6, 2022 - 4:51am

SHANGHAI, July 5, 2022 /PRNewswire/ -- Industry-leading new mobility and intelligent driving technology company, Human Horizons, has recently unveiled more details on the ultra-futuristic digital GT HiPhi Z. Redefining the traditional GT model, the HiPhi Z comes equipped with cutting edge technologies to create an unparalleled next-level driving experience.

Key Points: 
  • SHANGHAI, July 5, 2022 /PRNewswire/ -- Industry-leading new mobility and intelligent driving technology company, Human Horizons, has recently unveiled more details on the ultra-futuristic digital GT HiPhi Z. Redefining the traditional GT model, the HiPhi Z comes equipped with cutting edge technologies to create an unparalleled next-level driving experience.
  • "Designed and manufactured exclusively by Human Horizons, the HiPhi Z is a testament to the company's dedication to technological advancement, sparing no expense in testing the boundaries of creation.
  • Through rigorous testing and development, the HiPhi Z has retained more than 95% of its production intents revealed previously," said Ding Lei, founder, CEO, and chairman of HiPhi.
  • Furthermore, Human Horizons builds smart transportation technologies and contributes to the development of smart cities, which will redefine human mobility.

Viemed Announces Publication of Peer-Reviewed NIVH Study Finding Treatment Reduces Healthcare Costs and Saves Lives

Retrieved on: 
Tuesday, July 5, 2022 - 9:15pm

Certain statements contained in this press release may constitute forward-looking statements within the meaning of the U.S.

Key Points: 
  • Certain statements contained in this press release may constitute forward-looking statements within the meaning of the U.S.
  • Private Securities Litigation Reform Act of 1995 or forward-looking information as such term is defined in applicable Canadian securities legislation (collectively, forward-looking statements).
  • Any such forward-looking statements are expressly qualified in their entirety by this cautionary statement.
  • Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking statements.

Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors

Retrieved on: 
Tuesday, July 5, 2022 - 10:00pm

Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors.

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors.
  • We are pleased to welcome Dr. Shan to Cerus Board of Directors, said Daniel Swisher, Chair of the Board.
  • I am delighted to be joining the Board of Directors at Cerus during this exciting time in the Companys history, said Dr. Shan.
  • Cerus Corporation is dedicated solely to safeguarding the worlds blood supply and aims to become the preeminent global blood products company.

Multi-Instrumentalist James A. Norkawich Creates His Unique Brand Of Classical Crossover Music

Retrieved on: 
Tuesday, July 5, 2022 - 9:55pm

GLASTONBURY, Conn., July 5, 2022 /PRNewswire/ -- Jazz pianist and composer James A. Norkawich brings his own diverse musical background to the mainstream with a new music genre referred to as "Classical Crossover".

Key Points: 
  • GLASTONBURY, Conn., July 5, 2022 /PRNewswire/ -- Jazz pianist and composer James A. Norkawich brings his own diverse musical background to the mainstream with a new music genre referred to as "Classical Crossover".
  • By covering modern songs and using classically trained artists to craft unique arrangements, Norkawich blends old and new in brilliant fashion.
  • Using classical music as a background for more contemporary sounds, Norkawich collaborates with other musicians to bring a modern spin to a more traditional sound.
  • Through the Classical Crossover community he asked Tyrone Piper if he would would make a vocal imprint on a Queen classic.

Aviat Completes Redline Transaction

Retrieved on: 
Tuesday, July 5, 2022 - 9:05pm

AUSTIN, Texas, and TORONTO, July 5, 2022 /PRNewswire/ -- Aviat Networks, Inc. (NASDAQ: AVNW), the leading expert in wireless transport solutions, and Redline Communications Group Inc. ("Redline") (TSX: RDL), a leading provider in mission-critical data infrastructure, today announced the completion of the acquisition of Redline by a subsidiary of Aviat pursuant to a statutory plan of arrangement under the Canada Business Corporations Act (the "Arrangement"), which now enables Aviat to offer its customers an integrated end-to-end offering for wireless access and transport.

Key Points: 
  • "We are very pleased to close this transaction so that we will now be able to offer our customers a complete solution, including Private LTE/5G," said Peter Smith, CEO of Aviat Networks.
  • Aviat will include Redline in its FY23 guidance which will be provided in the next earnings call.
  • Redline was not part of Aviat during FY22 and will not be included in Aviat's forthcoming FY22 Q4 results.
  • For clarity, Aviat would like to reaffirm its previous FY22 guidance of $296-$300 million in revenue and $37-$39 million in Adjusted EBITDA.

National Sleep Foundation Announces New Board of Directors

Retrieved on: 
Tuesday, July 5, 2022 - 7:30pm

WASHINGTON, July 5, 2022 /PRNewswire/ -- Effective July 1, Temitayo Oyegbile-Chidi, MD, PhD, Associate Professor, Department of Neurology, at UC Davis, and Adjunct Professor, Department of Neurology, at Georgetown University Hospital will serve as Chair of the Board of Directors for the National Sleep Foundation (NSF). As Chair of the National Sleep Foundation, Dr. Oyegbile-Chidi will lead a Board of Directors composed of clinicians, researchers, and business professionals.

Key Points: 
  • As Chair of the National Sleep Foundation, Dr. Oyegbile-Chidi will lead a Board of Directors composed of clinicians, researchers, and business professionals.
  • Temitayo Oyegbile-Chidi, MD, PhD, will serve as Chair of the Board of Directors for the National Sleep Foundation.
  • "Dr. Oyegbile-Chidi has expertise in multiple topics includingneurology, sleep disorders, epilepsy, and younger populations which will help NSF continue its work to improve sleep health for all," said John Lopos, National Sleep Foundation CEO.
  • The National Sleep Foundation (NSF) is a 501(c)3 nonprofit corporation dedicated to improving health and well-being through sleep education and advocacy.